Video Shorts

1:11

Targeting ENPP3 in RCC

7 months ago

Randy F. Sweis, MD

1:00

Prostate Cancer Topics to Watch at ASCO GU 2026

7 months ago

Mehmet Asim Bilen, MD

0:49

Bladder Cancer Abstracts to Watch at ASCO GU 2026

7 months ago

Jad Chahoud, MD, MPH, MHA

1:47

Zanzalintinib Plus Atezolizumab Is One Step Closer to FDA Approval in Previously Treated mCRC

7 months ago

Anwaar Saeed, MD

1:22

Kidney Cancer Abstracts to Watch at ASCO GU 2026

7 months ago

Jad Chahoud, MD, MPH, MHA

Malin Hultcrantz, MD, PhD, discusses FDA draft guidance on MRD end points in multiple myeloma clinical trials.

1:03

FDA Draft Guidance on MRD End Points in Myeloma Trials

7 months ago

Malin Hultcrantz, MD, PhD

0:41

Overused Buzzwords in Hematology and Oncology

7 months ago

Riley Kandel

0:31

Tackling Lifileucel in Metastatic Melanoma and Other Topics at TCT 2026

7 months ago

Amrita Desai, MD, MPH

0:37

Hematologic Oncologists Share Conference Must-Haves

7 months ago

Riley Kandel

0:34

Zanidatamab-Based Regimens Could Be A ‘Game Changer’ for First-Line HER2+ GEA Paradigm

7 months ago

Raji Shameem, MD

1:40

TCT 2026: CAR T-Cell Therapy Expert Insights

7 months ago

Ashling Wahner

Philippos Costa, MD, and Hari Deshpande, MD

0:2.02

International Chondrosarcoma Awareness Day: Targeted Therapies Gain Ground in Rare Bone Cancer

7 months ago

Philippos Costa, MD(+1 more)

0:28

Previewing Loncastuximab Tesirine in Heavily Pretreated Patients With Diffuse Large B-Cell Lymphoma

7 months ago

Fernando Gibran-Nunes, MD

0:58

Prophylactic Dexamethasone Mitigating Neurotoxicity in Multiple Myeloma

7 months ago

Kenneth Jin Chang Lim, MBBS

1:24

The Role of Molecular and Genetic Testing in Ph+ Acute Lymphoblastic Leukemia

7 months ago

Nicholas J. Short, MD

1:05

5-Year Data Update from the Phase 2 ELARA Trial

7 months ago

Peter Riedell, MD

0:55

Tackling the Barriers to Cervical Cancer Screening

8 months ago

Robert Neff, MD

4:00

OncLive Recognizes World Cancer Day

8 months ago

Ronac Mamtani, MD, MSCE(+3 more)

0:43

Unpacking OS Data from the ROSELLA Trial

8 months ago

Alexander B. Olawaiye, MD

Justin Call, MD, and D. Ross Camidge, MD, PhD

2:11

How I Discovered My True Calling in Oncology

8 months ago

Ross Camidge, MD, PhD(+1 more)

1:43

Optimizing HPV Vaccination for Cancer Prevention

8 months ago

Maurie Markman, MD

1:49

Implications of FDA Draft Guidance on MRD End Points in Myeloma Trials

8 months ago

Rahul Banerjee, MD

0:21

Outlining the Results of the HER2CLIMB-05 Trial in HER2+ Breast Cancer

8 months ago

Erika P. Hamilton, MD

0:54

Increasing Clinical Trial Access in Gynecologic Oncology

8 months ago

Katherine Kurnit, MD, MPH

1:25

Highlighting the Importance of the Bionic Breast Program

8 months ago

Stacy Tessler Lindau, MD, MA

0:38

The Role of Clinical Trials in Gynecologic Oncology

8 months ago

John Moroney, MD

1:22

Expert Insight on AI in Oncology and Clinical Trials at University of Chicago Comprehensive Cancer Center

8 months ago

Riley Kandel

1:18

Examining the Future of Bispecifics and CAR T-Cell Therapy in Lymphoma

8 months ago

Alexandra Rojek, MD

Molecularly Driven Therapies Drive Ongoing Research in MPNs

1:48

Molecularly Driven Therapies Highlight Ongoing Research in MPNs

8 months ago

John O. Mascarenhas, MD

1:06

Addressing the Need for Cancer Screening in Young Adults

8 months ago

Sonali M. Smith, MD

Video Shorts

Trending on OncLive

ASCO Issues First Living Guideline for Systemic Treatment of Recurrent Ovarian Cancer

OSE2101 Plus Pembrolizumab as Maintenance Boosts PFS in Platinum-Sensitive Ovarian Cancer

FDA Approves Imlunestrant Plus Abemaciclib for ER+, HER2–, ESR1-Mutated Metastatic Breast Cancer

The OncFive: Top Oncology Articles for the Week of 9/14/2026

OncLive Weekly News Quiz (9/19/2026): Did You Catch the Latest NETs, Lung, Mastocytosis, and Pancreatic Cancer News?